Literature DB >> 33646496

Left atrial volume and function measured by cardiac magnetic resonance imaging as predictors of shocks and mortality in patients with implantable cardioverter-defibrillators.

Inna Y Gong1, Payam Yazdan-Ashoori1, Laura Jimenez-Juan2,3,4, Nigel S Tan1,5, Paul Angaran1,5, Binita Riya Chacko2,3, Saif Al-Mousawy1, Sheldon M Singh1,6, Tamar Shalmon3,4, Luciano Folador3,4, Iqwal Mangat1,5, Djeven P Deva3,4, Andrew T Yan7,8,9,10.   

Abstract

Left atrial (LA) volume and function (LA ejection fraction, LAEF) have demonstrated prognostic value in various cardiovascular diseases. We investigated the incremental value of LA volume and LAEF as measured by cardiovascular magnetic resonance imaging (CMR) for prediction of appropriate implantable cardioverter defibrillator (ICD) shock or all-cause mortality, in patients with ICD. We conducted a retrospective, multi-centre observational cohort study of patients who underwent CMR prior to primary or secondary prevention ICD implantation. A single, blinded reader measured maximum LA volume index (maxLAVi), minimum LA volume index (minLAVi), and LAEF. The primary outcome was a composite of independently adjudicated appropriate ICD shock or all-cause death. A total of 392 patients were enrolled. During a median follow-up time of 61 months, 140 (35.7%) experienced an appropriate ICD shock or died. Higher maxLAVi and minLAVi, and lower LAEF were associated with greater risk of appropriate ICD shock or death in univariate analysis. However, in multivariable analysis, LAEF (HR 0.92 per 10% higher, 95% CI 0.81-1.04, p = 0.17) and maxLAVi (HR 1.02 per 10 ml/m2 higher, 95% CI 0.93-1.12, p = 0.72) were not independent predictors of the primary outcome. In conclusion, LA volume and function measured by CMR were univariate but not independent predictors of appropriate ICD shocks or mortality. These findings do not support the routine assessment of LA volume and function to refine risk stratification to guide ICD implant. Larger studies with longer follow-up are required to further delineate the clinical implications of LA size and function.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.

Entities:  

Keywords:  Cardiovascular magnetic resonance imaging; Implantable cardioverter-defibrillator; Left atrial function; Left atrial volume; Outcomes

Year:  2021        PMID: 33646496     DOI: 10.1007/s10554-021-02196-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  28 in total

1.  Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry.

Authors:  Avi Sabbag; Mahmoud Suleiman; Avishag Laish-Farkash; Nimer Samania; Mark Kazatsker; Ilan Goldenberg; Michael Glikson; Roy Beinart
Journal:  Heart Rhythm       Date:  2015-08-13       Impact factor: 6.343

2.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

3.  Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy.

Authors:  Jeffrey J Goldberger; Haris Subačius; Taral Patel; Ryan Cunnane; Alan H Kadish
Journal:  J Am Coll Cardiol       Date:  2014-01-18       Impact factor: 24.094

4.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

Review 5.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Sana M Al-Khatib; William G Stevenson; Michael J Ackerman; William J Bryant; David J Callans; Anne B Curtis; Barbara J Deal; Timm Dickfeld; Michael E Field; Gregg C Fonarow; Anne M Gillis; Christopher B Granger; Stephen C Hammill; Mark A Hlatky; José A Joglar; G Neal Kay; Daniel D Matlock; Robert J Myerburg; Richard L Page
Journal:  J Am Coll Cardiol       Date:  2017-10-30       Impact factor: 24.094

6.  Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy.

Authors:  Fahad Almehmadi; Sebastien Xavier Joncas; Immaculate Nevis; Mohammad Zahrani; Mahmoud Bokhari; John Stirrat; Nowell M Fine; Raymond Yee; James A White
Journal:  Circ Cardiovasc Imaging       Date:  2014-06-05       Impact factor: 7.792

Review 7.  Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe?

Authors:  P Santangeli; A Dello Russo; M Casella; G Pelargonio; L Di Biase; A Natale
Journal:  Intern Med J       Date:  2011-01       Impact factor: 2.048

8.  Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.

Authors:  Lars Køber; Jens J Thune; Jens C Nielsen; Jens Haarbo; Lars Videbæk; Eva Korup; Gunnar Jensen; Per Hildebrandt; Flemming H Steffensen; Niels E Bruun; Hans Eiskjær; Axel Brandes; Anna M Thøgersen; Finn Gustafsson; Kenneth Egstrup; Regitze Videbæk; Christian Hassager; Jesper H Svendsen; Dan E Høfsten; Christian Torp-Pedersen; Steen Pehrson
Journal:  N Engl J Med       Date:  2016-08-27       Impact factor: 91.245

9.  Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.

Authors:  Wayne C Levy; Kerry L Lee; Anne S Hellkamp; Jeanne E Poole; Dariush Mozaffarian; David T Linker; Aldo P Maggioni; Inder Anand; Philip A Poole-Wilson; Daniel P Fishbein; George Johnson; Jill Anderson; Daniel B Mark; Gust H Bardy
Journal:  Circulation       Date:  2009-08-24       Impact factor: 29.690

Review 10.  Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction.

Authors:  Justin A Ezekowitz; Brian H Rowe; Donna M Dryden; Nicola Hooton; Ben Vandermeer; Carol Spooner; Finlay A McAlister
Journal:  Ann Intern Med       Date:  2007-08-21       Impact factor: 25.391

View more
  1 in total

1.  Cardiac magnetic resonance left atrial volumes and function to predict appropriate device therapy and death.

Authors:  Ming-Yen Ng; Jessica Poon; Andrew Li
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-17       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.